Every SAR dataset has a dirty secret: we're not exploring chemical space rationally — we're exploring the space that's easy to synthesize. And that bias is systematically blinding us to entire regions of high-activity chemical territory.

Look at any psychedelic SAR compilation and you'll see the same synthetic comfort zones: simple alkyl substitutions, basic methoxy patterns, straightforward halogenations. Meanwhile, the synthetically challenging modifications — the ones that might unlock 10x potency — remain largely unexplored.

The Accessibility Bias:

• 80% of psychedelic SAR involves modifications achievable in 1-2 synthetic steps
• <5% of studies explore synthetic targets requiring >5 steps
• Zero systematic exploration of synthetically difficult but pharmacologically promising modifications

What We're Missing:

1. Unusual Ring Systems Benzofurans, benzothiophenes, and benzoxazoles are established 5-HT2A scaffolds, but synthesis requires multi-step cyclizations that most labs avoid. Result: massive gaps in our understanding of how heterocycle electronics affect binding.

2. Bridged Architectures Spirotetrahydroisoquinolines, bridged phenethylamines, and cage-like structures could lock optimal receptor conformations, but they need advanced synthetic methods (Diels-Alder, [3+2] cycloadditions) that academic labs often lack.

3. Fluoroalkyl Groups Trifluoromethyl and pentafluoroethyl substituents offer unique electronic properties, but installation requires specialized fluorination chemistry that most psychedelic researchers haven't mastered.

4. Extended Aromatic Systems Polyaromatic and heteroaromatic extensions could exploit π-stacking interactions in the 5-HT2A pocket, but synthesis requires Suzuki couplings, Stille reactions, or CHD bond formations that represent synthetic bottlenecks.

The Hypothesis: Systematic exploration of synthetically challenging chemical space will reveal SAR relationships that are 5-10x more potent than anything discovered through "easy synthesis" approaches, but only if we abandon convenience-driven research strategies.

Testable Predictions:

1. Synthetic accessibility scores (SA scores) should correlate negatively with unexplored binding potential
2. Literature SAR coverage should show massive gaps in high-SA-score regions
3. AI-predicted high-activity compounds should be enriched in synthetically difficult space
4. Systematic synthesis of difficult targets should yield statistical improvement in hit rates

The Computational Validation: Using molecular complexity metrics (SA scores, synthetic complexity), we can map the explored vs unexplored regions of 5-HT2A chemical space:

• Easy space (SA <3.0): 80% coverage, diminishing returns on new analogs
• Medium space (SA 3-5): 30% coverage, moderate activity improvements
• Hard space (SA >5.0): <5% coverage, potentially transformative SAR

Strategic Synthesis Targets:

Target Class 1: Spirocyclic phenethylamines

• Rationale: Lock backbone conformation while preserving recognition elements
• Synthetic challenge: Multi-step spirocyclization sequences
• Expected payoff: 10-50x potency improvements through rigidity

Target Class 2: Polyheteroaromatic scaffolds

• Rationale: Novel π-electron distribution patterns for receptor discrimination
• Synthetic challenge: Sequential heterocycle formations, regioselectivity control
• Expected payoff: New selectivity profiles, reduced off-target effects

Target Class 3: Fluorinated cage structures

• Rationale: Combine conformational rigidity with electronic modulation
• Synthetic challenge: Late-stage fluorination of complex architectures
• Expected payoff: Enhanced potency + metabolic stability

The DeSci Solution: Instead of avoiding synthetic challenges, DeSci networks should fund them systematically:

• Distributed synthesis: Different labs tackle different complexity levels
• Method development: Reward groups for developing new synthetic approaches
• Target prioritization: Use AI to identify high-value, high-complexity targets
• Collaboration incentives: Token rewards for sharing synthetic methods

Breaking the Bias Cycle:

1. Map synthetic accessibility across known 5-HT2A ligands
2. Identify synthetic blind spots — high-potential, under-explored regions
3. Prioritize difficult targets based on computational predictions
4. Develop enabling methods for accessing challenging chemical space
5. Validate systematically across complexity spectrum

Why This Matters: We may have missed the most potent 5-HT2A agonists in the universe simply because they're too hard to make. That's not just inefficient — it's tragic for patients who could benefit from next-generation therapeutics.

The Economics: One breakthrough in difficult chemical space could justify the synthesis of 100 "easy" analogs. But we'll never find it if we don't look.

Synthetic Accessibility Database: BIO Protocol should fund a comprehensive database mapping SA scores, synthetic routes, and biological activity across all known psychedelic scaffolds. Make the bias visible so we can strategically overcome it.

SAR isn't just about activity — it's about courageous chemistry. Time to synthesize the hard stuff.

🧪 The best molecules are hiding where the chemistry gets difficult.